[1] 方凯,马爱娟,李航, 等.北京市40～79岁居民糖尿病与空腹血糖受损流行病学现状及其危险因素研究[J].中国全科医学,2019,22(9):1014-1020.
[2] IGNATEVA P A, BALLYUZEK M F, SHPAKOV A O. Age characteristics of the cardiovascular system, depending on the thyroid function in type 2 diabetes mellitus[J].Adv Gerontol,2015,28(4):755-761.
[3] 中华医学会内分泌学分会.成人甲状腺功能减退症诊治指南[J].中华内分泌代谢杂志,2017,33(2):167-180.
[4] GIUGLIANO D, MAIORINO M I, BELLASTELLA G,et al.Type 2 diabetes and cardiovascular prevention: the dogmas disputed[J].Endocrine,2018,60(2):224-228.
[5] ARCHUNDIA H M, SUBHAN F B, CHAN C B. Dietary patterns and cardiovascular disease risk in people with Type 2 Diabetes[J].Curr Obes Rep,2017,6(4):405-413.
[6] MOURA N A.Relationship of thyroid hormone levels and cardiovascular events in patients with type 2 diabetes[J].Endocrine,2014,45(1):84-91.
[7] JUN J E, JIN S M, JEE J H, et al. TSH increment and the risk of incident type 2 diabetes mellitus in euthyroid subjects[J].Endocrine,2017,55(3):944-953.
[8] 杨华,王述进,左红,等.脂代谢指标、血清hs-CRP水平在2型糖尿病亚临床甲状腺功能减退患者中的表达及其意义[J].医学临床研究,2017,34(12):2312-2315.
[9] 任晓丽,刘娟,杨姣.2型糖尿病对甲减患者血脂心功能及心血管事件的影响[J].河北医学,2019,25(10):1711-1715.
[10] JABBAR A, PINGITORE A, PEARCE S H, et al. Thyroid hormones and cardiovascular disease[J].Nat Rev Cardiol,2017,14(1):39-55.
[11] ALRAWAHI A H, LEE P, AL-ANQOUDI Z, et al. Cardiovascular risk prediction model for Omanis with type 2 diabetes[J].Diabetes Metab Syndr,2018,12(2):105-110.
2022, Vol. 39 
